Nascent Biotech, Inc. (NBIO)

Nascent Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Net Income	-2.09	-2.8	-0.15	-1.31	-4.09
Depreciation & Amortization	0.38	1.34	0	0	0
Share-Based Compensation	0.06	0.68	0.12	0.79	1.1
Other Operating Activities	0.46	-1.01	0.45	-0.46	2.43
Operating Cash Flow	-1.19	-1.79	0.41	-0.99	-0.55
Common Stock Issued	1.56	0.21	0	0.64	0.12
Other Financing Activities	-0.18	1.66	-0.32	0.35	0.31
Financing Cash Flow	1.39	1.87	-0.32	0.99	0.43
Net Cash Flow	0.2	0.08	0.09	-0	-0.13
Free Cash Flow	-1.19	-1.79	0.41	-0.99	-0.55
Free Cash Flow Margin	-	-	41.35%	-131.57%	-
Free Cash Flow Per Share	-0.01	-0.02	0.00	-0.01	-0.02

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.